Anzeige
Meldung des Tages: China kartiert den Meeresboden. Das Pentagon fordert Nickel. Ein Unternehmen mit 27 Mio. CAD Bewertung hat soeben reagiert.

Insmed News

Aktie
WKN:  A1JJA3 ISIN:  US4576693075 US-Symbol:  INSM Branche:  Biotechnologie Land:  USA
144,47 $
+1,68 $
+1,18%
122,81 € 17.04.26
Depot/Watchlist
Marktkapitalisierung *
27,47 Mrd. €
Streubesitz
-
KGV
-28,49
Nachhaltigkeits-Score
53 %
Index-Zuordnung
Nasdaq 100
Weiter aufwärts? Long handeln - Jetzt mit Hebel 7,39: MM2MA0
Werbung

Insmed News

30.10.25 - PR Newswire
Insmed Reports Third-Quarter 2025 Financial Results and Provides Business Update
Insmed Reports Third-​Quarter 2025 Financial Results and Provides Business Update PR Newswire
23.10.25 - PR Newswire
Insmed Ranks No. 1 on Science's 2025 Top Biopharma Employers List
Insmed Ranks No. 1 on Science's 2025 Top Biopharma Employers List PR Newswire
17.10.25 - PR Newswire
CHMP Recommends EU Approval of BRINSUPRI™ (brensocatib) for the Treatment of Non-Cystic Fibrosis Bronchiectasis
CHMP Recommends EU Approval of BRINSUPRI™ (brensocatib) for the Treatment of Non-​Cystic Fibrosis Bronchiectasis PR Newswire
16.10.25 - PR Newswire
Insmed to Present Multiple Analyses from Phase 3 ASPEN Study at the American College of Chest Physicians Annual Meeting 2025
Insmed to Present Multiple Analyses from Phase 3 ASPEN Study at the American College of Chest Physicians Annual Meeting 2025 PR Newswire
15.10.25 - PR Newswire
Insmed to Host Third-Quarter 2025 Financial Results Conference Call on Thursday, October 30, 2025
Insmed to Host Third-​Quarter 2025 Financial Results Conference Call on Thursday, October 30, 2025 PR Newswire
22.09.25 - PR Newswire
Insmed to Present Multiple Abstracts at the European Respiratory Society Congress 2025
Insmed to Present Multiple Abstracts at the European Respiratory Society Congress 2025 PR Newswire
05.09.25 - PR Newswire
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire
27.08.25 - PR Newswire
Bloomberg 500 (B500) Index Adds Sixteen Securities Following Semi-Annual Reconstitution
Bloomberg 500 (B500) Index Adds Sixteen Securities Following Semi-​Annual Reconstitution PR Newswire
22.08.25 wallstreetONLINE Redaktion
Stars & Flops: Diese Aktien lieben die Hedgefonds – und diese nicht
Hedgefonds verraten ihre Favoriten: Capital One, Skechers & Co. gewinnen rasant an Beliebtheit – während Giganten wie Alphabet, Pfizer und Chipotle bei den Profis ...
21.08.25 - PR Newswire
Insmed To Present at September Investor Conferences
Insmed To Present at September Investor Conferences PR Newswire
12.08.25 - PR Newswire
FDA Approves BRINSUPRI™ (brensocatib) as the First and Only Treatment for Non-Cystic Fibrosis Bronchiectasis, a Serious, Chronic Lung Disease
FDA Approves BRINSUPRI™ (brensocatib) as the First and Only Treatment for Non-​Cystic Fibrosis Bronchiectasis, a Serious, Chronic Lung Disease PR Newswire
07.08.25 - PR Newswire
Insmed Reports Second-Quarter 2025 Financial Results and Provides Business Update
Insmed Reports Second-​Quarter 2025 Financial Results and Provides Business Update PR Newswire
04.08.25 - PR Newswire
Late-Stage Pipeline Wins Boost Investor Confidence in High-Growth Therapeutic Areas
Late-​Stage Pipeline Wins Boost Investor Confidence in High-​Growth Therapeutic Areas PR Newswire
04.08.25 - PR Newswire
Late-Stage Pipeline Wins Boost Investor Confidence in High-Growth Therapeutic Areas
Late-​Stage Pipeline Wins Boost Investor Confidence in High-​Growth Therapeutic Areas PR Newswire
11.06.25 - PR Newswire
Insmed Announces Pricing of $750 Million Public Offering of Common Stock
Insmed Announces Pricing of $750 Million Public Offering of Common Stock PR Newswire
11.06.25 - PR Newswire
Insmed Announces Proposed $650 Million Public Offering of Common Stock
Insmed Announces Proposed $650 Million Public Offering of Common Stock PR Newswire
10.06.25 - PR Newswire
Insmed Announces Positive Topline Results from Phase 2b Study of Treprostinil Palmitil Inhalation Powder (TPIP) as Once-Daily Therapy in Patients with Pulmonary Arterial Hypertension
Insmed Announces Positive Topline Results from Phase 2b Study of Treprostinil Palmitil Inhalation Powder (TPIP) as Once-​Daily Therapy in Patients with Pulmonary Arterial ...
04.06.25 - PR Newswire
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire
25.05.25 wallstreetONLINE Redaktion
Neue Favoriten: Multimilliardär Druckenmiller tauscht Nvidia, Amazon & Tesla gegen diese High-Potential-Aktien
Top-​Investor Stanley Druckenmiller kehrt Aktien wie Nvidia, Amazon, Palantir und Tesla den Rücken, während er diese aussichtsreichen Werte aufstockt.Stanley Druckenmiller ...
21.05.25 - PR Newswire
Brensocatib Shows Consistent Efficacy and Safety Across Three Prespecified Subgroups in New Data from Landmark ASPEN Study
Brensocatib Shows Consistent Efficacy and Safety Across Three Prespecified Subgroups in New Data from Landmark ASPEN Study PR Newswire

Newssuche

Videos

newspaper
16.04.26 +2,80%
Technical Trading: Treffsichere Signale für Gold
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »